LumellaPOC | Preeclampsia and Gestational Diabetes Point-of-Care Test
home,page,page-id-20631,page-template,page-template-full_width,page-template-full_width-php,ajax_fade,page_not_loaded,,select-theme-ver-2.4,wpb-js-composer js-comp-ver-4.7.4,vc_responsive

Our New Point-of-Care Blood Tests Help Determine Your Risk for Preeclampsia and Gestational Diabetes.

These tests utilize glycosylated fibronectin, a new pregnancy-specific metabolic biomarker, along with other hormones, to accurately assess your risk for developing preeclapmsia and/ or gestational diabetes.


The tests only require a simple finger stick and can be performed in your physician’s office during the first or second trimester of your pregnancy.